Company Filing History:
Years Active: 2022-2025
Title: Innovations by Jeffrey Richard Salm
Introduction
Jeffrey Richard Salm, based in Wakefield, MA, USA, is a notable inventor whose work has significantly contributed to advancements in the field of protein manufacturing. With a total of three patents to his name, Salm's innovations focus on methods that enhance the safety and efficacy of protein production processes, particularly through viral inactivation.
Latest Patents
Salm's latest patent is centered around "Methods for continuously inactivating a virus during the manufacture of a protein." This groundbreaking technique involves several key steps that ensure the safety of protein products. The process begins with combining a composition that includes the protein and a virus-inactivation reagent at a predetermined volumetric ratio to form a treatment composition. This composition is then transferred to a treatment vessel, where it undergoes incubation under specific conditions. Finally, the treatment composition is subjected to a post-treatment processing operation. This method emphasizes a continuous approach without feedback control adjustments, ensuring the stability of the treatment composition across varying protein concentrations.
Career Highlights
Jeffrey Richard Salm has made significant strides in his career by working with Boehringer Ingelheim International GmbH. His focus on creating safer methods for protein manufacture highlights his commitment to innovation and improving industry standards. With three patents attributed to him, Salm continues to push the boundaries of what is possible in biopharmaceutical manufacturing.
Collaborations
Salm has collaborated with esteemed colleagues, including Marcus Andre Fiadeiro and Jonathan Coffman. These partnerships have proven essential in the development and refinement of his patented methods, fostering an environment of shared knowledge and expertise that benefits the field of protein manufacturing.
Conclusion
Jeffrey Richard Salm is a prominent figure in the realm of innovations in protein production. With his latest patents focused on enhancing safety through effective viral inactivation methods, he continues to contribute to the advancement of biopharmaceutical technologies. Collaborating with talented peers at Boehringer Ingelheim International GmbH, Salm remains a key player in driving innovation forward in this critical area of healthcare.